Eligible articles were critically appraised using a modification of the Scottish Intercollegiate Guidelines Network criteria.13 Two reviewers independently reviewed and extracted data from accepted articles into evidence tables. A third reviewer was consulted for PD0325901 nmr disagreements. The evidence was synthesized according to the modified Scottish Intercollegiate

Guidelines Network criteria, and a best-evidence synthesis was performed to provide clear and useful conclusions linked to the evidence tables. We also categorized the evidence on prognostic factors as exploratory or confirmatory, using the phases of study framework described by Côté et al.14 Phase I studies are hypothesis-generating investigations that explore the associations between potential prognostic factors and disease outcomes in a descriptive or univariate way. Phase II studies are extensive exploratory analyses that focus on particular sets of prognostic factors, or attempt to discover

which factors have the highest prognostic value. Both phase I and phase Panobinostat manufacturer II studies provide preliminary evidence. Lastly, phase III studies are large confirmatory studies of explicit prestated hypotheses that allow for a focused examination of the strength, direction, and independence of the proposed relationship between a prognostic factor and the outcome of interest. The strongest evidence is found in phase III studies, followed by phase II. Phase I studies do not consider confounding and are weaker evidence.

Of 77,914 records screened for our entire review, 121 full-text articles related to sport concussion were assessed for eligibility (fig 1).11 There were 52 English articles that assessed sport concussion and met our eligibility criteria. About half of these (n=24) were accepted as scientifically admissible articles, represented by 19 studies (table 1). These studies form the basis of our best-evidence synthesis. We accepted 19 cohort studies, of which 10 were phase II and 9 were phase I. Fourteen studies were conducted in the United States, 4 in Australia, and 1 in Canada. Most participants were male and played American football at the high school, collegiate, or professional level. Follow-up periods varied, with most high school and collegiate athletes being followed up for a few days to 12 weeks. Professional athletes were Tau-protein kinase followed for up to 4 seasons. The findings are divided into 6 sections relating to the different outcome variables reviewed: (1) cognitive function; (2) postconcussion symptoms; (3) recurrent concussion; (4) RTP; (5) sport performance; and (6) course and predictors of recovery after sport concussion. We accepted 7 phase II9, 15, 16, 17, 18, 19 and 20 and 5 phase I21, 22, 23, 24, 25 and 26 studies. The findings were inconsistent because of varied patient characteristics, study designs, follow-up periods, and assessments of exposures and outcomes.